← back to search

Xiaoyan Feng

Nanchang University · CN
Area of research
Hematology · Pathology and Forensic Medicine
Research interest
Research interests include Medicine, Multiple myeloma, Transport engineering, Internal medicine, Beijing, and Business.
h-index
citations
536
works
8
NIH funding
primary concept
email

Recent publications

A novel approach to wound healing: Green synthetic nano-zinc oxide embedded with sodium alginate and polyvinyl alcohol hydrogels for dressings
International Journal of Pharmaceutics 2024cited by 24position: middledoi
Pattern diversity based trip-level impact evaluation on mileage and emissions of on-demand ride-splitting
Transportation Research Part C Emerging Technologies 2024cited by 4position: middledoi
Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma
JAMA Oncology 2022cited by 58position: middledoi
Understanding the factors associated with one-way and round-trip carsharing usage based on a hybrid operation carsharing system: A case study in Beijing
Travel Behaviour and Society 2022cited by 14position: firstdoi
Trip chain based usage patterns analysis of the round-trip carsharing system: A case study in Beijing
Transportation Research Part A Policy and Practice 2020cited by 38position: firstdoi
Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study
Blood Advances 2019cited by 13position: middledoi
APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment
Blood 2016cited by 353position: middledoi
Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma
Oncotarget 2016cited by 107position: middledoi
Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma
Leukemia Research 2015cited by 25position: middledoi
Detection of recurrent cytogenetic aberrations in multiple myeloma: A comparison between MLPA and iFISH
Oncotarget 2015cited by 20position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Lugui Qiu · Chinese Academy of Medical Sciences & Peking Union Medical College5 papers (2015–2019) · 4 papers (2015–2019)Dehui Zou · Tianjin University of Technology4 papers (2015–2019)Gang An · Harbin Medical University4 papers (2015–2019)Yan Xu · Guangzhou University of Chinese Medicine4 papers (2015–2019)Huijun Sun · Dalian Medical University3 papers (2020–2024)Chirag Acharya · Jackson Memorial Hospital3 papers (2015–2016)Shuhua Yi · Southwest General Health Center3 papers (2015–2019)Mu Hao · University of Iowa3 papers (2015–2016)Ying Lv · Shanxi Medical University3 papers (2020–2024)Weiwei Sui · Hebei Agricultural University3 papers (2015–2019) · 3 papers (2015–2019)Xiaoqi Qin · Shanxi Medical University3 papers (2015–2019)Meirong Zang · Hebei Medical University3 papers (2015–2019)Zengjun Li · West China Medical Center of Sichuan University3 papers (2015–2019)Yu‐Tzu Tai · Cancer Research Center2 papers (2016–2016)Fei Li · Hebei Medical University2 papers (2015–2015)Yu Qin · Guangzhou University of Chinese Medicine2 papers (2015–2019)Kun Ru · The First Affiliated Hospital, Sun Yat-sen University2 papers (2015–2016)Fenghuang Zhan · Cancer Research Center1 papers (2015–2015)